×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Olema Pharmaceuticals Inc. (OLMA) NASDAQ

$8.92 0.19 (2.12%)

Market Cap: $488.30M

As of 05/24/24 12:02 PM EDT. Market open.

(OLMA)

Olema Pharmaceuticals Inc. (OLMA)
NASDAQ

$8.92
0.19 (2.12%)

Market Cap: $488.30M

As of 05/24/24 12:02 PM EDT. Market open.

Add to Portfolio

olema oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. our lead program, op-1250, a potential best-in-class complete estrogen receptor antagonist (ceran), is in development to treat estrogen receptor-positive (er+), human epidermal growth factor receptor 2-negative (her2-) breast cancer. olema recently initiated a phase 1/2 dose-escalation ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
83
Address
.
PRICE CHART FOR OLEMA PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.84
Previous Close
$8.73
Days Range
$8.62 - $9.34
52 week range
$5.02 - $17.79
Volume
224,180
Avg. Volume (30 days)
752,811
Market Cap
$488.30M
Dividend Yield
-
P/E
-
Shares Outstanding
55,933,827
Open
$8.84
Previous Close
$8.73
Days Range
$8.62 - $9.34
52 week range
$5.02 - $17.79
Volume
224,180
Avg. Volume (30 days)
752,811
Market Cap
$488.30M
Dividend Yield
-
P/E
-
Shares Outstanding
55,933,827
FINANCIAL STATEMENTS FOR OLEMA PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OLEMA PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Harmon CyrusDirectorMay 06, 2024 Sale$10.925,00054,600806,283May 07, 2024, 05:00 PM
Harmon CyrusDirectorApr 30, 2024 Sale$9.5115,000142,650811,283May 02, 2024, 05:09 PM
Harmon CyrusDirectorMar 28, 2024 Sale$10.9720,000219,400826,283Mar 29, 2024, 05:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERMar 18, 2024 Option Exercise$4.8713,70066,71980,364Mar 20, 2024, 05:30 PM
Harmon CyrusDirectorFeb 29, 2024 Sale$12.4125,000310,309846,383Mar 04, 2024, 05:30 PM
Harmon CyrusDirectorFeb 01, 2024 Sale$15.565,00077,800871,283Feb 02, 2024, 05:00 PM
Harmon CyrusDirectorJan 31, 2024 Sale$12.2325,000305,750876,283Feb 02, 2024, 05:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERJan 25, 2024 Option Exercise$7.0220,000140,40066,664Jan 29, 2024, 07:30 AM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Jan 12, 2024 Option Exercise$7.0250,000351,000484,987Jan 16, 2024, 07:30 AM
Harmon CyrusDirectorDec 29, 2023 Sale$13.3825,000334,500903,783Jan 02, 2024, 05:30 PM
Graham G. WalmsleyDirectorSep 12, 2023 Buy$9.84508,1304,999,9991,668,130Dec 18, 2023, 06:30 PM
Graham G. WalmsleyDirectorDec 05, 2023 Buy$14.19131,8701,871,2801,800,000Dec 18, 2023, 06:30 PM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Dec 12, 2023 Option Exercise$7.0210,00070,200434,987Dec 12, 2023, 05:55 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERDec 11, 2023 Option Exercise$7.022,90020,35846,664Dec 12, 2023, 05:55 PM
Paradigm Biocapital Advisors LP10% OwnerDec 06, 2023 Buy$11.60100,0001,160,0006,590,981Dec 08, 2023, 04:19 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERDec 06, 2023 Option Exercise$7.0213,10091,96243,764Dec 07, 2023, 08:30 PM
Harmon CyrusDirectorNov 30, 2023 Sale$12.5725,000314,250926,283Dec 01, 2023, 05:15 PM
Harmon CyrusDirectorNov 22, 2023 Sale$13.903,98955,447951,283Nov 22, 2023, 07:00 PM
Harmon CyrusDirectorNov 21, 2023 Sale$14.864,19262,293955,272Nov 22, 2023, 07:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERNov 21, 2023 Sale$14.847,461110,74737,959Nov 22, 2023, 07:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERNov 22, 2023 Sale$13.897,09598,55030,664Nov 22, 2023, 07:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 22, 2023 Sale$13.896,65392,410574,099Nov 22, 2023, 07:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 21, 2023 Sale$14.886,976103,823580,952Nov 22, 2023, 07:00 PM
Bohen SeanPRESIDENT AND CEONov 22, 2023 Sale$13.9027,932388,255144,925Nov 22, 2023, 07:00 PM
Bohen SeanPRESIDENT AND CEONov 21, 2023 Sale$14.8829,293435,879175,459Nov 22, 2023, 07:00 PM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Nov 22, 2023 Sale$13.899,145127,024424,987Nov 22, 2023, 07:00 PM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Nov 21, 2023 Sale$14.869,597142,632434,832Nov 22, 2023, 07:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 08, 2023 Sale$17.612003,522561,270Nov 13, 2023, 05:30 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 01, 2023 Sale$15.026,668100,153565,343Nov 03, 2023, 09:39 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 03, 2023 Sale$17.515419,473561,470Nov 03, 2023, 09:39 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 02, 2023 Sale$15.363,33251,180562,011Nov 03, 2023, 09:39 PM
Harmon CyrusDirectorNov 02, 2023 Sale$15.645,00078,200943,714Nov 02, 2023, 08:50 PM
Harmon CyrusDirectorOct 31, 2023 Sale$12.0525,000301,250948,714Nov 02, 2023, 08:50 PM
Harmon CyrusDirectorSep 29, 2023 Sale$12.4125,000310,250973,714Oct 03, 2023, 05:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFSep 19, 2023 Sale$12.6720,000253,400572,011Sep 21, 2023, 05:00 PM
BVF PARTNERS L P/ILDirectorSep 12, 2023 Buy$9.841,505,93214,818,3714,688,954Sep 14, 2023, 04:25 PM
Harmon CyrusDirectorSep 05, 2023 Sale$11.6210,000116,200998,714Sep 05, 2023, 09:08 PM
Harmon CyrusDirectorAug 31, 2023 Sale$9.3615,000140,4001,008,714Sep 05, 2023, 09:08 PM
Harmon CyrusDirectorAug 16, 2023 Sale$10.1415,000152,1001,023,714Sep 05, 2023, 04:05 PM
Harmon CyrusDirectorAug 16, 2023 Sale$10.1415,000152,1001,023,714Aug 17, 2023, 05:00 PM
Harmon CyrusDirectorJun 08, 2023 Sale$6.3010,00063,0001,038,714Jun 09, 2023, 05:30 PM
Harmon CyrusDirectorJun 06, 2023 Sale$6.305,00031,4751,048,714Jun 07, 2023, 09:30 PM
Harmon CyrusDirectorJun 05, 2023 Sale$6.055,00030,2251,053,714Jun 07, 2023, 09:30 PM
BVF PARTNERS L P/ILDirectorJun 10, 2022 Buy$4.03200,000806,9003,913,676Jun 14, 2022, 04:46 PM
Horn KinneyCHIEF BUSINESS OFFICERMar 10, 2022 Option Exercise$2.065,25310,8427,711Mar 14, 2022, 04:45 PM
Horn KinneyCHIEF BUSINESS OFFICERMar 10, 2022 Sale$4.755,25324,9522,458Mar 14, 2022, 04:45 PM
Horn KinneyCHIEF BUSINESS OFFICERFeb 10, 2022 Option Exercise$2.065,25110,8387,709Feb 14, 2022, 05:18 PM
Horn KinneyCHIEF BUSINESS OFFICERJan 10, 2022 Option Exercise$2.065,25110,8387,709Jan 11, 2022, 08:21 PM
Horn KinneyCHIEF BUSINESS OFFICERJan 10, 2022 Sale$6.855,25135,9692,458Jan 11, 2022, 08:21 PM
Horn KinneyCHIEF BUSINESS OFFICERDec 10, 2021 Option Exercise$2.065,25110,8387,709Dec 14, 2021, 04:25 PM
Horn KinneyCHIEF BUSINESS OFFICERDec 10, 2021 Sale$10.395,25154,5582,458Dec 14, 2021, 04:25 PM
Myles David C.CHIEF DEVELOPMENT OFFICERDec 10, 2021 Sale$10.3010,000103,000582,901Dec 14, 2021, 04:03 PM
BVF PARTNERS L P/ILDirectorNov 30, 2021 Buy$9.39739,6756,945,7703,755,093Dec 02, 2021, 08:45 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERNov 29, 2021 Sale$24.764009,9041,051,146Dec 01, 2021, 05:34 PM
Horn KinneyCHIEF BUSINESS OFFICERNov 10, 2021 Option Exercise$15.7927,668436,76129,458Nov 12, 2021, 05:15 PM
Horn KinneyCHIEF BUSINESS OFFICERNov 10, 2021 Sale$26.8827,668743,7161,790Nov 12, 2021, 05:15 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICEROct 19, 2021 Sale$27.9812,000335,7941,056,101Oct 21, 2021, 04:33 PM
Bohen SeanPRESIDENT AND CEOOct 14, 2021 Option Exercise$4.825,00024,12057,514Oct 15, 2021, 06:44 PM
Bohen SeanPRESIDENT AND CEOOct 14, 2021 Sale$30.475,000152,36352,865Oct 15, 2021, 06:44 PM
Horn KinneyCHIEF BUSINESS OFFICEROct 11, 2021 Option Exercise$2.065,25110,8387,041Oct 12, 2021, 06:53 PM
Horn KinneyCHIEF BUSINESS OFFICEROct 11, 2021 Sale$27.905,251146,5104,936Oct 12, 2021, 06:53 PM
Bohen SeanPRESIDENT AND CEOSep 27, 2021 Option Exercise$4.821,0855,23453,599Sep 29, 2021, 07:56 PM
Bohen SeanPRESIDENT AND CEOSep 27, 2021 Sale$30.071,08532,62652,514Sep 29, 2021, 07:56 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERSep 20, 2021 Sale$26.3012,000315,6001,063,546Sep 21, 2021, 06:19 PM
Horn KinneyCHIEF BUSINESS OFFICERSep 10, 2021 Option Exercise$2.065,25110,8387,041Sep 13, 2021, 08:07 PM
Horn KinneyCHIEF BUSINESS OFFICERSep 10, 2021 Sale$29.385,251154,2741,790Sep 13, 2021, 08:07 PM
Bohen SeanPRESIDENT AND CEOSep 07, 2021 Option Exercise$4.824131,99254,687Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 08, 2021 Option Exercise$4.822,63112,69256,905Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 07, 2021 Sale$30.0841312,42354,274Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 08, 2021 Sale$30.002,63178,93052,514Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 01, 2021 Option Exercise$4.828714,20255,145Sep 03, 2021, 05:16 PM
Bohen SeanPRESIDENT AND CEOSep 01, 2021 Sale$30.0587126,17454,274Sep 03, 2021, 05:16 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERAug 19, 2021 Sale$24.9712,000299,6401,075,546Aug 20, 2021, 09:14 PM
Horn KinneyCHIEF BUSINESS OFFICERAug 10, 2021 Option Exercise$2.065,25110,8387,041Aug 11, 2021, 06:05 PM
Horn KinneyCHIEF BUSINESS OFFICERAug 10, 2021 Sale$25.715,251134,9791,850Aug 11, 2021, 06:05 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERJul 20, 2021 Sale$25.634,123105,6721,087,546Jul 21, 2021, 05:29 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERJul 19, 2021 Sale$24.837,877195,5861,091,669Jul 21, 2021, 05:29 PM
Horn KinneyCHIEF BUSINESS OFFICERJul 12, 2021 Option Exercise$2.065,25110,8387,041Jul 13, 2021, 06:27 PM
Horn KinneyCHIEF BUSINESS OFFICERJul 12, 2021 Sale$26.515,251139,1913,182Jul 13, 2021, 06:27 PM
Horn KinneyCHIEF BUSINESS OFFICERMay 18, 2021 Option Exercise$2.0657,763119,22359,553May 19, 2021, 08:18 PM
Horn KinneyCHIEF BUSINESS OFFICERMay 18, 2021 Sale$24.1557,7631,394,76910,411May 19, 2021, 08:18 PM
Cormorant Asset Management, LPFormer 10% OwnerNov 23, 2020 Buy$19.00425,0008,075,0003,270,544Nov 23, 2020, 04:59 PM
Graham G. WalmsleyDirectorNov 23, 2020 Buy$19.001,160,00022,040,0001,160,000Nov 23, 2020, 04:35 PM
BVF PARTNERS L P/ILDirectorNov 19, 2020 Buy$19.001,135,33421,571,3463,392,663Nov 20, 2020, 08:02 PM
BUTITTA CYNTHIA MDirectorSep 16, 2020 Option Exercise$4.4183,876369,55883,876Nov 19, 2020, 06:42 PM
Bohen SeanPresident and CEOSep 23, 2020 Option Exercise$4.8251,649249,15551,649Nov 19, 2020, 06:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Harmon CyrusDirector05/06/202454,600
Harmon CyrusDirector04/30/2024142,650
Harmon CyrusDirector03/28/2024219,400
Zojwalla NaseemCHIEF MEDICAL OFFICER03/18/202466,719
Harmon CyrusDirector02/29/2024310,309
Harmon CyrusDirector02/01/202477,800
Harmon CyrusDirector01/31/2024305,750
Zojwalla NaseemCHIEF MEDICAL OFFICER01/25/2024140,400
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.01/12/2024351,000
Harmon CyrusDirector12/29/2023334,500
Graham G. WalmsleyDirector09/12/20234,999,999
Graham G. WalmsleyDirector12/05/20231,871,280
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.12/12/202370,200
Zojwalla NaseemCHIEF MEDICAL OFFICER12/11/202320,358
Paradigm Biocapital Advisors LP10% Owner12/06/20231,160,000
Zojwalla NaseemCHIEF MEDICAL OFFICER12/06/202391,962
Harmon CyrusDirector11/30/2023314,250
Harmon CyrusDirector11/22/202355,447
Harmon CyrusDirector11/21/202362,293
Zojwalla NaseemCHIEF MEDICAL OFFICER11/21/2023110,747
Zojwalla NaseemCHIEF MEDICAL OFFICER11/22/202398,550
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/22/202392,410
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/21/2023103,823
Bohen SeanPRESIDENT AND CEO11/22/2023388,255
Bohen SeanPRESIDENT AND CEO11/21/2023435,879
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.11/22/2023127,024
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.11/21/2023142,632
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/08/20233,522
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/01/2023100,153
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/03/20239,473
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/02/202351,180
Harmon CyrusDirector11/02/202378,200
Harmon CyrusDirector10/31/2023301,250
Harmon CyrusDirector09/29/2023310,250
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF09/19/2023253,400
BVF PARTNERS L P/ILDirector09/12/202314,818,371
Harmon CyrusDirector09/05/2023116,200
Harmon CyrusDirector08/31/2023140,400
Harmon CyrusDirector08/16/2023152,100
Harmon CyrusDirector08/16/2023152,100
Harmon CyrusDirector06/08/202363,000
Harmon CyrusDirector06/06/202331,475
Harmon CyrusDirector06/05/202330,225
BVF PARTNERS L P/ILDirector06/10/2022806,900
Horn KinneyCHIEF BUSINESS OFFICER03/10/202210,842
Horn KinneyCHIEF BUSINESS OFFICER03/10/202224,952
Horn KinneyCHIEF BUSINESS OFFICER02/10/202210,838
Horn KinneyCHIEF BUSINESS OFFICER01/10/202210,838
Horn KinneyCHIEF BUSINESS OFFICER01/10/202235,969
Horn KinneyCHIEF BUSINESS OFFICER12/10/202110,838
Horn KinneyCHIEF BUSINESS OFFICER12/10/202154,558
Myles David C.CHIEF DEVELOPMENT OFFICER12/10/2021103,000
BVF PARTNERS L P/ILDirector11/30/20216,945,770
Harmon CyrusCHIEF TECHNOLOGY OFFICER11/29/20219,904
Horn KinneyCHIEF BUSINESS OFFICER11/10/2021436,761
Horn KinneyCHIEF BUSINESS OFFICER11/10/2021743,716
Harmon CyrusCHIEF TECHNOLOGY OFFICER10/19/2021335,794
Bohen SeanPRESIDENT AND CEO10/14/202124,120
Bohen SeanPRESIDENT AND CEO10/14/2021152,363
Horn KinneyCHIEF BUSINESS OFFICER10/11/202110,838
Horn KinneyCHIEF BUSINESS OFFICER10/11/2021146,510
Bohen SeanPRESIDENT AND CEO09/27/20215,234
Bohen SeanPRESIDENT AND CEO09/27/202132,626
Harmon CyrusCHIEF TECHNOLOGY OFFICER09/20/2021315,600
Horn KinneyCHIEF BUSINESS OFFICER09/10/202110,838
Horn KinneyCHIEF BUSINESS OFFICER09/10/2021154,274
Bohen SeanPRESIDENT AND CEO09/07/20211,992
Bohen SeanPRESIDENT AND CEO09/08/202112,692
Bohen SeanPRESIDENT AND CEO09/07/202112,423
Bohen SeanPRESIDENT AND CEO09/08/202178,930
Bohen SeanPRESIDENT AND CEO09/01/20214,202
Bohen SeanPRESIDENT AND CEO09/01/202126,174
Harmon CyrusCHIEF TECHNOLOGY OFFICER08/19/2021299,640
Horn KinneyCHIEF BUSINESS OFFICER08/10/202110,838
Horn KinneyCHIEF BUSINESS OFFICER08/10/2021134,979
Harmon CyrusCHIEF TECHNOLOGY OFFICER07/20/2021105,672
Harmon CyrusCHIEF TECHNOLOGY OFFICER07/19/2021195,586
Horn KinneyCHIEF BUSINESS OFFICER07/12/202110,838
Horn KinneyCHIEF BUSINESS OFFICER07/12/2021139,191
Horn KinneyCHIEF BUSINESS OFFICER05/18/2021119,223
Horn KinneyCHIEF BUSINESS OFFICER05/18/20211,394,769
Cormorant Asset Management, LPFormer 10% Owner11/23/20208,075,000
Graham G. WalmsleyDirector11/23/202022,040,000
BVF PARTNERS L P/ILDirector11/19/202021,571,346
BUTITTA CYNTHIA MDirector09/16/2020369,558
Bohen SeanPresident and CEO09/23/2020249,155
Load More Insider Transactions
FUNDS WITH A POSITION IN OLEMA PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,216,5540.00085%-1.45%Other
VIVO CAPITAL, LLC1,873,7041.67%No changeOther
GEODE CAPITAL MANAGEMENT, LLC839,3450.00088%1.76%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.460,0000.00983%-8%Other
CANDRIAM S.C.A.353,0180.03%64.19%Other
RENAISSANCE TECHNOLOGIES LLC173,6110.00377%ExitedOther
ALPS ADVISORS INC38,8610.00311%1.83%Other
D. E. SHAW & CO., INC.10,1000.0001%-15.05%Other
AQR CAPITAL MANAGEMENT LLC11,4210.00022%5.94%Other
CHANGE IN SHARES OUTSTANDING FOR OLEMA PHARMACEUTICALS INC
STOCK BUYBACKS FOR OLEMA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.60%
1Q
12/31/2023
06/30/2023
11.12%
2Q
12/31/2023
03/31/2023
12.12%
3Q
12/31/2023
12/31/2022
12.58%
4Q
12/31/2023
09/30/2022
13.02%
5Q
12/31/2023
06/30/2022
13.35%
6Q
12/31/2023
03/31/2022
13.59%
7Q
12/31/2023
12/31/2021
13.84%
8Q
12/31/2023
09/30/2021
14.24%
9Q
12/31/2023
06/30/2021
14.80%
10Q
12/31/2023
03/31/2021
15.06%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.60%
1Q
06/30/2023
11.12%
2Q
03/31/2023
12.12%
3Q
12/31/2022
12.58%
4Q
09/30/2022
13.02%
5Q
06/30/2022
13.35%
6Q
03/31/2022
13.59%
7Q
12/31/2021
13.84%
8Q
09/30/2021
14.24%
9Q
06/30/2021
14.80%
10Q
03/31/2021
15.06%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OLEMA PHARMACEUTICALS INC
LOADING...